Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the operating margin high or low?
The operating margin of -27450.00% is 1368% below its 5-year average of -1869.84%, near the low end of its 5-year range (-35812.50%–2300.00%).
Reported quarterly operating margin; no daily interpolation. Q2 FY2026 (2026-06-30): 0.00%.
OPERATING MARGIN
-27450.00%
OPERATING MARGIN AVG TTM
0.00%
OPERATING MARGIN AVG 3Y
-1062.55%
OPERATING MARGIN AVG 5Y
-1869.84%
OPERATING MARGIN AVG 10Y
-1742.55%
OPERATING MARGIN AVG 15Y
N/A
OPERATING MARGIN AVG 20Y
N/A
CURRENT VS TTM AVG
N/A
CURRENT VS 3Y AVG
-2483.40%
CURRENT VS 5Y AVG
-1368.04%
CURRENT VS 10Y AVG
-1475.28%
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
0.00%
median of 862 covered companies
CURRENT VS SECTOR MEDIAN
N/A
vs the sector median at left
Entera Bio Ltd.
Market Cap
$124.70M
Operating Margin
-27450.00%
TTM Avg
0.00%
3Y Avg
-1062.55%
5Y Avg
-1869.84%
Market Cap
$124.18M
Operating Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$122.66M
Operating Margin
-959.05%
TTM Avg
-1156.66%
3Y Avg
-959.32%
5Y Avg
-639.55%
Market Cap
$122.43M
Operating Margin
-33.18%
TTM Avg
-17.71%
3Y Avg
-9.45%
5Y Avg
-4.00%
Market Cap
$127.29M
Operating Margin
-1324.41%
TTM Avg
-662.21%
3Y Avg
-331.10%
5Y Avg
-220.74%
Market Cap
$127.98M
Operating Margin
-609.18%
TTM Avg
-581.63%
3Y Avg
-290.81%
5Y Avg
-193.88%
Market Cap
$120.58M
Operating Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$120.41M
Operating Margin
-483.85%
TTM Avg
-600.79%
3Y Avg
-640.11%
5Y Avg
-1468.53%
Market Cap
$119.84M
Operating Margin
-1853.92%
TTM Avg
-1829.87%
3Y Avg
-8864.53%
5Y Avg
-5959.13%
| NAME | MARKET CAP | OPERATING MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Entera Bio Ltd. (ENTX) | $124.70M | -27450.00% | 0.00% | -1062.55% | -1869.84% |
| TuHURA Biosciences, Inc. (HURA)vs › | $124.18M | 0.00% | 0.00% | 0.00% | 0.00% |
| Tonix Pharmaceuticals Holding Corp. (TNXP)vs › | $122.66M | -959.05% | -1156.66% | -959.32% | -639.55% |
| BGM Group Ltd. (BGM)vs › | $122.43M | -33.18% | -17.71% | -9.45% | -4.00% |
| NRx Pharmaceuticals, Inc. (NRXP)vs › | $127.29M | -1324.41% | -662.21% | -331.10% | -220.74% |
| Pyxis Oncology, Inc. (PYXS)vs › | $127.98M | -609.18% | -581.63% | -290.81% | -193.88% |
| enGene Holdings Inc. (ENGN)vs › | $120.58M | 0.00% | 0.00% | 0.00% | 0.00% |
| Seer, Inc. (SEER)vs › | $120.41M | -483.85% | -600.79% | -640.11% | -1468.53% |
| Cibus, Inc. (CBUS)vs › | $119.84M | -1853.92% | -1829.87% | -8864.53% | -5959.13% |
| LENZ Therapeutics, Inc. (LENZ)vs › | $118.83M | -477.46% | -238.73% | -136.84% | -91.23% |
Gross Margin
0.0%
Operating Margin
-27450.0%
Operating Margin = Operating Income / Revenue
Operating margin is the percentage of revenue remaining after operating expenses, reflecting operating efficiency.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | OPERATING MARGIN |
|---|---|
| 2026-06-30 | 0.00% |
| 2026-03-31 | 0.00% |
| 2025-12-31 | 0.00% |
| 2025-09-30 | 0.00% |
| 2025-06-30 | 0.00% |
| 2025-03-31 | -6102.38% |
| 2024-12-31 | -2850.00% |
| 2024-09-30 | -7192.86% |
| 2024-06-30 | -3798.25% |
| 2024-03-31 | 0.00% |
| 2023-12-31 | 0.00% |
| 2023-09-30 | 0.00% |
| 2023-06-30 | 0.00% |
| 2023-03-31 | 0.00% |
| 2022-12-31 | -22042.86% |
| 2022-09-30 | -35812.50% |
| 2022-06-30 | -7384.09% |
| 2022-03-31 | -5639.71% |
| 2021-12-31 | -2501.82% |
| 2021-09-30 | 2300.00% |
| 2021-06-30 | -2357.80% |
| 2021-03-31 | -1489.81% |
| 2020-12-31 | -1038.46% |
| 2020-09-30 | -4832.00% |
| 2020-06-30 | -6782.69% |
| 2020-03-31 | -6892.86% |
| 2019-12-31 | -3426.47% |
| 2019-09-30 | -4731.67% |
| 2019-06-30 | -2741.89% |
| 2019-03-31 | 0.00% |
| 2018-12-31 | -496.60% |
| 2018-09-30 | 0.00% |
| 2018-06-30 | 0.00% |
| 2018-03-31 | 0.00% |
| 2017-12-31 | 0.00% |
| 2017-09-30 | 0.00% |
| 2017-06-30 | 0.00% |
| 2017-03-31 | 0.00% |
| 2016-12-31 | 0.00% |
| 2016-09-30 | 0.00% |
| 2016-06-30 | 0.00% |
| 2016-03-31 | 0.00% |
